Dark
Light
System
Institutional Investment Manager
SABBY MANAGEMENT, LLC
SABBY MANAGEMENT, LLC (CIK: 0001535610) incorporated in Delaware, located at 1011 Links Dr, Miami Beach, FL. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q1)
Portfolio Summary: 294 holdings with a total value of $1,998,933,000.
#
Name
Shares
Value ($)
%
Options
Notes
151 SYNERGY PHARMACEUTICALS DEL 392,273 1,083,000 0.05%
152 CHAMPIONS ONCOLOGY INC 295,328 1,075,000 0.05%
153 XTL BIOPHARMACEUTICALS LTD 1,040,194 1,073,000 0.05%
154 MAST THERAPEUTICS INC COM 3,877,356 1,062,000 0.05%
155 INSMED INC 771 977,000 0.05% Put
156 REGULUS THERAPEUTICS INC COM 140,000 970,000 0.05%
157 MANNKIND CORP 6,000 966,000 0.05% Call
158 ZAFGEN INC 1,446 966,000 0.05% Call
159 SAGE THERAPEUTICS INC 293 939,000 0.05% Call
160 ONCOTHYREON INC COM N/C EFF 6/ 739,004 939,000 0.05%
161 DISCOVERY LABORATORIES INC N 566,352 934,000 0.05%
162 TONIX PHARMACEUTICALS HOLDING 385,248 928,000 0.05%
163 INTERCEPT PHARMACEUTICALS IN 72 925,000 0.05% Put
164 QUEST RESOURCE HOLDING CORP 2,131,914 895,000 0.04%
165 INOTEK PHARMACEUTICALS CORP 116,454 862,000 0.04%
166 ABEONA THERAPEUTICS INC 334,108 855,000 0.04%
167 IGNYTA INC COM 125,000 846,000 0.04%
168 BioPharmX Corporation 775,000 845,000 0.04%
169 ARALEZ PHARMACEUTICALS INC 236,364 839,000 0.04%
170 THERAPEUTICSMD INC 130,400 835,000 0.04%
171 TOBIRA THERAPEUTICS INC 100,000 818,000 0.04%
172 ACHILLION PHARMACEUTICALS IN 105,648 816,000 0.04%
173 SANGAMO THERAPEUTICS INCORPORATED 134,500 814,000 0.04%
174 ARIAD PHARMACEUTICALS INC 1,265 808,000 0.04% Call
175 CYNAPSUS THERAPEUTICS INC 66,522 792,000 0.04%
176 PSIVIDA CORP 293,585 787,000 0.04%
177 ACHILLION PHARMACEUTICALS IN 1,005 776,000 0.04% Put
178 WAFERGEN BIO-SYSTEMS INC 1,195,470 765,000 0.04%
179 ALCOBRA LTD 200,868 761,000 0.04%
180 IONIS PHARMACEUTICALS INC 186 753,000 0.04% Put
181 CYTOKINETICS INC 1,066 752,000 0.04% Call
182 Otonomy Inc 50,000 746,000 0.04%
183 BENITEC BIOPHARMA LTD 422,101 739,000 0.04%
184 ProQR Therapeutics NV 149,934 732,000 0.04%
185 VTV THERAPEUTICS INC 139,747 721,000 0.04%
186 ANTHERA PHARMACEUTICALS I 198,918 720,000 0.04%
187 BELLICUM PHARMACEUTICALS INCORPORATED 77,020 720,000 0.04%
188 EXELIXIS INC 1,783 713,000 0.04% Call
189 ANTARES PHARMA INC 775,212 675,000 0.03%
190 Natera, Inc. 69,272 659,000 0.03%
191 HORIZON PHARMA PLC 390 646,000 0.03% Put
192 PTC THERAPEUTICS INC 1,000 644,000 0.03% Call
193 RELYPSA INC 473 641,000 0.03% Call
194 Capnia, Inc. 530,524 637,000 0.03%
195 OMEROS CORP 415 637,000 0.03% Call
196 CYCLACEL PHARMACEUTICALS INC 1,632,259 628,000 0.03%
197 HEAT BIOLOGICS INC 902,007 626,000 0.03%
198 COMBIMATRIX CORP 911,041 610,000 0.03%
199 AKARI THERAPEUTICS PLC 40,705 606,000 0.03%
200 PROGENICS PHARMACEUTICALS IN 1,384 603,000 0.03% Call
Page 4 of 6

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-101848, filed 2016.05.13).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.